Phase 1 Cancer Clinical Trials: A Practical Guide
Autor Elizabeth A Eisenhauer, Christopher Twelves, Marc Buyseen Limba Engleză Paperback – 20 iul 2006
Preț: 482.65 lei
Preț vechi: 663.62 lei
-27% Nou
Puncte Express: 724
Preț estimativ în valută:
92.40€ • 96.04$ • 76.61£
92.40€ • 96.04$ • 76.61£
Carte tipărită la comandă
Livrare economică 25-31 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780198567196
ISBN-10: 0198567197
Pagini: 360
Ilustrații: 20 black and white line illustrations, numerous tables
Dimensiuni: 151 x 232 x 20 mm
Greutate: 0.56 kg
Ediția:10
Editura: OUP OXFORD
Colecția OUP Oxford
Locul publicării:Oxford, United Kingdom
ISBN-10: 0198567197
Pagini: 360
Ilustrații: 20 black and white line illustrations, numerous tables
Dimensiuni: 151 x 232 x 20 mm
Greutate: 0.56 kg
Ediția:10
Editura: OUP OXFORD
Colecția OUP Oxford
Locul publicării:Oxford, United Kingdom
Recenzii
[This] is the first book to concentrate on this particular phase of drug development in cancer...a truly hands-on guide for anyone interested in developing and running such trials. Oncology trainees and specialists involved in cancer drug development will find this book the definitive resource on Phase I cancer studies. Medical oncologists, haematologists, clinical pharmacologists, and pharamceutical companies will also find the book of interest.
This is both a comprehensive and complete overview of the important aspects critical for the development of phase 1 clinical trials.
This is both a comprehensive and complete overview of the important aspects critical for the development of phase 1 clinical trials.
Notă biografică
Elizabeth Eisenhauer was appointed to the Board of Directors of the National Cancer Institute of Canada in 2002, and will become President in June 2006. Through her work with the IND program and NCIC CTG, she has co-ordinated over 170 Phase I, II and III trials carried out across Canada, the US and Europe.Marc Buyse founded the International Drug Development Institute (IDDI) in 1991. In addition to his current posts, he has previously been President of the International Society for Clinical Biostatistics and a Board Member of the Society for Clinical Trials. He has an editorial role in the following journals: Biometrical Journal, Clinical Trials, Journal of Clinical Oncology, and Statistical Methods in Medical Research.